{"id":11068,"date":"2026-09-03T15:10:00","date_gmt":"2026-09-03T15:10:00","guid":{"rendered":"https:\/\/www.dhenne-avocats.fr\/?p=11068"},"modified":"2026-10-23T13:02:14","modified_gmt":"2026-10-23T13:02:14","slug":"contrefacon-imminente-jub-pharma","status":"publish","type":"post","link":"https:\/\/www.dhenne-avocats.fr\/ja\/contrefacon-imminente-jub-pharma\/","title":{"rendered":"UPC\u306b\u304a\u3051\u308b\u5dee\u3057\u8feb\u3063\u305f\u4fb5\u5bb3\u3068\u533b\u85ac\u54c1\u30ea\u30b9\u30af\u306e\u65b0\u305f\u306a\u5730\u7406"},"content":{"rendered":"<p><br \/>\n<br \/>\n<\/p>\n<p>\u533b\u85ac\u54c1\u5206\u91ce\u3067\u306f\u3001\u72ec\u5360\u671f\u9593\u306f\u6708\u5358\u4f4d\u3067\u6570\u3048\u3089\u308c\u3001\u305d\u306e\u4e00\u304b\u6708\u3054\u3068\u304c\u6570\u767e\u4e07\u30e6\u30fc\u30ed\u306b\u76f8\u5f53\u3057\u307e\u3059\u3002\u3057\u305f\u304c\u3063\u3066\u6c7a\u5b9a\u7684\u306a\u554f\u984c\u306f\u3001\u3082\u306f\u3084\u5f8c\u767a\u533b\u85ac\u54c1\u304c\u7279\u8a31\u3092\u4fb5\u5bb3\u3057\u3066\u3044\u308b\u304b\u5426\u304b\u3060\u3051\u3067\u306f\u306a\u304f\u3001\u4fb5\u5bb3\u3057\u3088\u3046\u3068\u3057\u3066\u3044\u308b\u304b\u5426\u304b\u306b\u3042\u308a\u307e\u3059\u3002\u3053\u308c\u3053\u305d\u304c\u5dee\u3057\u8feb\u3063\u305f\u4fb5\u5bb3\uff08contrefa\u00e7on imminente\uff09\u3068\u3044\u3046\u6982\u5ff5\u306e\u4e3b\u984c\u3067\u3042\u308a\u3001\u7d71\u4e00\u7279\u8a31\u88c1\u5224\u6240\uff08UPC\uff09\u306f\u3053\u306e\u6982\u5ff5\u3092\u5927\u304d\u304f\u5237\u65b0\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u6982\u5ff5\u4e0a\u306e\u7dca\u5f35\u95a2\u4fc2\u306f\u6b21\u306e\u3068\u304a\u308a\u3067\u3059\u3002\u3059\u3067\u306b\u884c\u308f\u308c\u305f\u884c\u70ba\u3092\u5236\u88c1\u3059\u308b\u305f\u3081\u306b\u69cb\u60f3\u3055\u308c\u305f\u6cd5\u304c\u3001\u84cb\u7136\u6027\u3092\u898f\u5f8b\u3057\u59cb\u3081\u3066\u3044\u308b\u306e\u3067\u3059\u3002UPC\u63a7\u8a34\u88c1\u5224\u6240\u306e<em>Boehringer c. Zentiva<\/em>\u5224\u6c7a\uff08UPC_CoA_446\/2025\u30012025\u5e748\u670813\u65e5\uff09\u306b\u3088\u308a\u3001\u4e89\u70b9\u306f\u3082\u306f\u3084\u4f55\u304c\u884c\u308f\u308c\u305f\u304b\u3067\u306f\u306a\u304f\u3001\u660e\u65e5\u4f55\u304c\u884c\u308f\u308c\u3046\u308b\u304b\u306b\u79fb\u308a\u307e\u3057\u305f\u3002\u7279\u8a31\u6cd5\u306f\u4e88\u6e2c\u7684\u306a\u3082\u306e\u3068\u306a\u308a\u3001\u5236\u88c1\u306e\u5236\u5ea6\u3067\u3042\u308b\u3068\u540c\u6642\u306b\u4e88\u9632\u306e\u5236\u5ea6\u3068\u3082\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5148\u767a\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u306b\u3068\u3063\u3066\u3082\u5f8c\u767a\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u306b\u3068\u3063\u3066\u3082\u3001\u3053\u306e\u5909\u5316\u306f\u30ea\u30b9\u30af\u306e\u5730\u7406\u3092\u63cf\u304d\u76f4\u3059\u3082\u306e\u3067\u3059\u3002<a href=\"\/ja\/domaines-d-expertise\/jub\/\">\u5358\u4e00\u306e\u88c1\u5224\u6240<\/a>\u306b\u304a\u3051\u308b\u4e00\u3064\u306e\u624b\u7d9a\u306b\u3088\u3063\u3066\u3001\u7de0\u7d04\u56fd\u306e\u5168\u9818\u57df\u3092\u5c01\u9396\u3059\u308b\u3053\u3068\u3082\u3001\u9006\u306b\u958b\u653e\u3059\u308b\u3053\u3068\u3082\u3001\u4eca\u3084\u53ef\u80fd\u3068\u306a\u308a\u307e\u3057\u305f\u3002<\/p>\n<h2>\u610f\u56f3\u304b\u3089\u84cb\u7136\u6027\u3078\uff1a\u4e8c\u3064\u306e\u6cd5\u7684\u8ad6\u7406<\/h2>\n<p>UPC\u4ee5\u524d\u306f\u3001\u5404\u52a0\u76df\u56fd\u304c\u72ec\u81ea\u306e\u5224\u65ad\u67a0\u7d44\u307f\u3092\u9069\u7528\u3057\u3066\u3044\u307e\u3057\u305f\u3002\u30d5\u30e9\u30f3\u30b9\u6cd5\u306f\u3001\u30d5\u30e9\u30f3\u30b9\u77e5\u7684\u8ca1\u7523\u6cd5\u5178L.615-3\u6761\u306b\u57fa\u3065\u304d\u3001\u610f\u56f3\u3092\u793a\u3059\u5916\u90e8\u7684\u306a\u5fb4\u8868\u3092\u63a2\u6c42\u3057\u3066\u3044\u307e\u3057\u305f\u3002\u3059\u306a\u308f\u3061\u3001\u533b\u7642\u88fd\u54c1\u7d4c\u6e08\u59d4\u54e1\u4f1a\uff08CEPS\uff09\u3078\u306e\u7533\u8acb\u3001\u8ca9\u4fc3\u30ad\u30e3\u30f3\u30da\u30fc\u30f3\u3001\u4fdd\u5065\u5f53\u5c40\u3078\u306e\u901a\u77e5\u306a\u3069\u3067\u3059\u3002<a href=\"\/ja\/lexique-propriete-intellectuelle\/autorisation-de-mise-sur-le-marche-amm\/\">\u8ca9\u58f2\u627f\u8a8d\uff08AMM\uff09<\/a>\u306e\u7533\u8acb\u306e\u307f\u3067\u306f\u3001\u4fb5\u5bb3\u304c\u5dee\u3057\u8feb\u3063\u3066\u3044\u308b\u3053\u3068\u3092\u7acb\u8a3c\u3059\u308b\u306b\u306f\u8db3\u308a\u307e\u305b\u3093\u3067\u3057\u305f\uff08\u30d1\u30ea\u5927\u5be9\u88c1\u5224\u6240\uff08TGI Paris\uff09\u30012010\u5e748\u670819\u65e5\u3001<em>Sanofi c. Teva<\/em>\uff09\u3002\u30c9\u30a4\u30c4\u6cd5\u306f\u3001\u5546\u696d\u7684\u884c\u70ba\u306e\u4e00\u9023\u306e\u6d41\u308c\u3092\u78ba\u7387\u8ad6\u7684\u306b\u5206\u6790\u3059\u308b\u3053\u3068\u3092\u91cd\u8996\u3057\u3001\u5951\u7d04\u4e0a\u306e\u9055\u7d04\u91d1\u3092\u4f34\u3046\u4e0d\u4f5c\u70ba\u5ba3\u8a00\uff08Unterlassungserkl\u00e4rung\uff09\u3092\u30ea\u30b9\u30af\u9664\u53bb\u306e\u4e2d\u5fc3\u7684\u306a\u624b\u6bb5\u3068\u3057\u3066\u3044\u307e\u3057\u305f\u3002<\/p>\n<p>UPC\u306f\u3001\u3088\u308a\u5ba2\u89b3\u7684\u306a\u57fa\u6e96\u3092\u63a1\u7528\u3057\u3066\u3044\u307e\u3059\u3002\u6e96\u5099\u304c\u5b8c\u4e86\u3057\u3001\u767a\u58f2\u304c\u3082\u306f\u3084\u88ab\u544a\u81ea\u8eab\u306e\u6c7a\u5b9a\u306e\u307f\u306b\u4f9d\u5b58\u3059\u308b\u6bb5\u968e\u306b\u9054\u3057\u3066\u3044\u308b\u304b\u3001\u3068\u3044\u3046\u57fa\u6e96\u3067\u3059\u3002\u7d71\u4e00\u7279\u8a31\u88c1\u5224\u6240\u5354\u5b9a\uff08UPCA\uff09\u7b2c62\u6761(1)\u306f\u3001\u5dee\u3057\u8feb\u3063\u305f\u4fb5\u5bb3\u3092\u9632\u6b62\u3059\u308b\u305f\u3081\u306e\u547d\u4ee4\u3092\u8a8d\u3081\u3066\u3044\u307e\u3059\u3002\u624b\u7d9a\u898f\u5247211\u6761(2)\u306f\u3001\u5341\u5206\u306a\u7a0b\u5ea6\u306e\u78ba\u5b9f\u6027\u3092\u3082\u305f\u3089\u3059\u5408\u7406\u7684\u306a\u8a3c\u62e0\u3092\u8981\u6c42\u3057\u3066\u3044\u307e\u3059\u3002\u9069\u7528\u3055\u308c\u308b\u57fa\u6e96\u306f\u300c\u305d\u3046\u3067\u306a\u3044\u3088\u308a\u3082\u305d\u3046\u3067\u3042\u308b\u53ef\u80fd\u6027\u304c\u9ad8\u3044\u300d\u3068\u3044\u3046\u3082\u306e\u3067\u3059\u3002\u30d5\u30e9\u30f3\u30b9\u6cd5\u306e\u7bc4\u7587\u3067\u3042\u308b\u610f\u56f3\u306f\u3001\u84cb\u7136\u6027\u306e\u8a08\u7b97\u306e\u4e2d\u306b\u5438\u53ce\u3055\u308c\u308b\u3053\u3068\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n<h2>Boehringer c. Zentiva\uff1a\u6e96\u5099\u304c\u5b9f\u884c\u306b\u7b49\u3057\u3044\u3068\u304d<\/h2>\n<p>\u30ea\u30b9\u30dc\u30f3\u5730\u65b9\u90e8\u306f\u3001\u30dd\u30eb\u30c8\u30ac\u30eb\u306b\u304a\u3051\u308b\u4e8b\u524d\u8a55\u4fa1\u624b\u7d9a\u304c\u5b8c\u4e86\u3057\u3066\u3044\u305f\u306b\u3082\u304b\u304b\u308f\u3089\u305a\u3001Zentiva\u306e\u884c\u70ba\u3092\u5358\u306a\u308b\u6e96\u5099\u884c\u70ba\u3068\u8a55\u4fa1\u3057\u3066\u3001Boehringer\u306b\u3088\u308b\u66ab\u5b9a\u63aa\u7f6e\u306e\u7533\u7acb\u3066\u3092\u68c4\u5374\u3057\u3066\u3044\u307e\u3057\u305f\uff08UPC_CFI_41\/2025\u30012025\u5e745\u67088\u65e5\uff09\u3002\u63a7\u8a34\u88c1\u5224\u6240\u306f2025\u5e748\u670813\u65e5\u3001\u3053\u306e\u6c7a\u5b9a\u3092\u53d6\u308a\u6d88\u3057\u307e\u3057\u305f\uff08\u6c7a\u5b9a\u6587\u306f<a href=\"https:\/\/www.unifiedpatentcourt.org\/en\/decisions-and-orders\" rel=\"nofollow\">UPC\u306e\u6c7a\u5b9a\u767b\u9332\u7c3f<\/a>\u3067\u95b2\u89a7\u3067\u304d\u307e\u3059\uff09\u3002<\/p>\n<p>\u305d\u306e\u7406\u7531\u3065\u3051\u306f\u6ce8\u76ee\u306b\u5024\u3057\u307e\u3059\u3002\u30dd\u30eb\u30c8\u30ac\u30eb\u5f53\u5c40\u306b\u3088\u308b\u4e8b\u524d\u901a\u77e5\u304c\u306a\u3044\u3053\u3068\u306f\u3001\u4fb5\u5bb3\u306e\u5dee\u3057\u8feb\u308a\u3092\u6392\u9664\u3059\u308b\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3067\u3057\u305f\u3002\u516c\u5171\u8abf\u9054\u306e\u5165\u672d\u3078\u306e\u53c2\u52a0\u306f\u3001UPCA\u7b2c25\u6761\u306e\u610f\u5473\u306b\u304a\u3051\u308b\u7533\u51fa\u306b\u8a72\u5f53\u3057\u3046\u308b\u3082\u306e\u3067\u3057\u305f\u3002Zentiva\u306f\u3001\u3053\u308c\u3089\u306e\u5165\u672d\u3078\u306e\u5b9f\u969b\u306e\u53c2\u52a0\u3092\u59a8\u3052\u308b\u6cd5\u7684\u969c\u5bb3\u3092\u4f55\u3089\u7acb\u8a3c\u3057\u3066\u3044\u307e\u305b\u3093\u3067\u3057\u305f\u3002\u3068\u308a\u308f\u3051\u3001\u4e8b\u524d\u8a55\u4fa1\u306f\u7279\u8a31\u6e80\u4e86\u306e1\u5e74\u4ee5\u4e0a\u524d\u3068\u3044\u3046\u7570\u4f8b\u306b\u65e9\u3044\u6642\u671f\u306b\u3001\u4fe1\u983c\u3067\u304d\u308b\u8aac\u660e\u3082\u306a\u304f\u53d6\u5f97\u3055\u308c\u3066\u3044\u307e\u3057\u305f\u3002\u63a7\u8a34\u88c1\u5224\u6240\u306f\u3001Zentiva\u304c\u4fb5\u5bb3\u3092\u53ef\u80fd\u306b\u3059\u308b\u3059\u3079\u3066\u306e\u8981\u7d20\u3092\u305d\u308d\u3048\u3066\u304a\u308a\u3001\u8ca9\u58f2\u306f\u3082\u306f\u3084\u540c\u793e\u81ea\u8eab\u306e\u6c7a\u5b9a\u306e\u307f\u306b\u4f9d\u5b58\u3057\u3066\u3044\u308b\u3068\u7d50\u8ad6\u3065\u3051\u307e\u3057\u305f\u3002<\/p>\n<p>\u30a2\u30c3\u30c8\u30ea\u30b9\u30af\u30fb\u30ed\u30fc\u30f3\u30c1\uff08lancement \u00e0 risque\uff09\u306e\u5b9f\u52d9\u306b\u3068\u3063\u3066\u6c7a\u5b9a\u7684\u306a\u6559\u8a13\u306f\u3001\u767a\u58f2\u3057\u306a\u3044\u65e8\u306e\u4e00\u65b9\u7684\u306a\u5ba3\u8a00\u3060\u3051\u3067\u306f\u3001\u305d\u3046\u3067\u306a\u3044\u3088\u308a\u3082\u305d\u3046\u3067\u3042\u308b\u53ef\u80fd\u6027\u304c\u9ad8\u3044\u3068\u7acb\u8a3c\u3055\u308c\u305f\u30ea\u30b9\u30af\u3092\u9664\u53bb\u3067\u304d\u306a\u3044\u3068\u3044\u3046\u3053\u3068\u3067\u3059\u3002\u304b\u3064\u3066\u306f\u5f8c\u767a\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u306b\u3068\u3063\u3066\u521d\u6b69\u7684\u306a\u614e\u91cd\u3055\u3067\u3042\u3063\u305f\u6c88\u9ed9\u304c\u3001\u4eca\u3084\u4e0d\u5229\u306a\u8a3c\u62e0\u3068\u306a\u308b\u306e\u3067\u3059\u3002<\/p>\n<h2>\u30dc\u30fc\u30e9\u30fc\u4f8b\u5916\u306e\u9650\u754c<\/h2>\n<p>Zentiva\u306f\u3001EU\u306e\u533b\u85ac\u54c1\u6cd5\u6539\u6b63\u6848\u3092\u63f4\u7528\u3057\u307e\u3057\u305f\u3002\u540c\u6848\u306e\u7b2c85\u6761\u306f\u3001<a href=\"\/ja\/lexique-propriete-intellectuelle\/exception-bolar\/\">\u30dc\u30fc\u30e9\u30fc\u4f8b\u5916<\/a>\u3092\u4fa1\u683c\u304a\u3088\u3073\u511f\u9084\u306e\u624b\u7d9a\u306b\u307e\u3067\u62e1\u5f35\u3059\u308b\u3082\u306e\u3067\u3059\u3002\u63a7\u8a34\u88c1\u5224\u6240\u306f\u3053\u306e\u4e3b\u5f35\u3092\u9000\u3051\u307e\u3057\u305f\u3002\u4ea4\u6e09\u4e2d\u306e\u6587\u66f8\u306f\u5b9f\u5b9a\u6cd5\u3067\u306f\u306a\u3044\u304b\u3089\u3067\u3059\u3002<\/p>\n<p>\u3082\u3063\u3068\u3082\u3001\u3053\u3053\u3067\u60c5\u5831\u306e\u66f4\u65b0\u304c\u5fc5\u8981\u3067\u3059\u30022025\u5e7412\u6708\u3001\u6b27\u5dde\u8b70\u4f1a\u3068\u7406\u4e8b\u4f1a\u306f<a href=\"https:\/\/www.europarl.europa.eu\/news\/en\/press-room\/20251209IPR32110\/deal-on-comprehensive-reform-of-eu-pharmaceutical-legislation\" rel=\"nofollow\">\u533b\u85ac\u54c1\u30d1\u30c3\u30b1\u30fc\u30b8\u306b\u95a2\u3059\u308b\u66ab\u5b9a\u5408\u610f<\/a>\u306b\u9054\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u5408\u610f\u306f\u3001\u8ca9\u58f2\u627f\u8a8d\uff08AMM\uff09\u3001\u533b\u7642\u6280\u8853\u8a55\u4fa1\u3001\u4fa1\u683c\u304a\u3088\u3073\u511f\u9084\u306e\u627f\u8a8d\u306e\u53d6\u5f97\u3001\u3042\u308b\u3044\u306f\u5165\u672d\u3078\u306e\u5fdc\u672d\u3092\u76ee\u7684\u3068\u3057\u3066\u884c\u308f\u308c\u308b\u8a66\u9a13\u3084\u624b\u7d9a\u306b\u307e\u3067\u3001\u514d\u9664\u3092\u660e\u793a\u7684\u306b\u62e1\u5f35\u3059\u308b\u3082\u306e\u3067\u3059\u3002\u3053\u306e\u5408\u610f\u306f\u3001\u306a\u304a\u6b63\u5f0f\u306b\u63a1\u629e\u3055\u308c\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u305d\u3057\u3066\u767a\u52b9\u5f8c\u3067\u3042\u3063\u3066\u3082\u3001\u5bfe\u8c61\u3068\u306a\u308b\u306e\u306f\u898f\u5236\u4e0a\u306e\u624b\u7d9a\u305d\u306e\u3082\u306e\u3067\u3042\u3063\u3066\u3001\u5b8c\u5168\u306a\u767a\u58f2\u4f53\u5236\u306e\u69cb\u7bc9\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<em>Boehringer<\/em>\u5224\u6c7a\u304c\u5f15\u3044\u305f\u3001\u514d\u9664\u3055\u308c\u308b\u6e96\u5099\u3068\u5dee\u3057\u8feb\u3063\u305f\u4fb5\u5bb3\u304c\u8a8d\u3081\u3089\u308c\u308b\u6bb5\u968e\u3068\u306e\u5883\u754c\u7dda\u306f\u3001\u5f15\u304d\u7d9a\u304d\u610f\u7fa9\u3092\u4fdd\u3064\u3053\u3068\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>\u624b\u7d9a\u9762\u3067\u306f\u3001\u63a7\u8a34\u88c1\u5224\u6240\u306f\u3001\u5c11\u306a\u304f\u3068\u308230\uff05\u306e\u4fa1\u683c\u4f4e\u4e0b\u3092\u4f34\u3046\u5f8c\u767a\u533b\u85ac\u54c1\u306e\u53c2\u5165\u304c\u3001\u304a\u305d\u3089\u304f\u56de\u5fa9\u4e0d\u80fd\u306a\u4fa1\u683c\u6d78\u98df\u3092\u3082\u305f\u3089\u3059\u3053\u3068\u3082\u8a8d\u3081\u307e\u3057\u305f\u3002\u3053\u308c\u306f<em>Sumi c. Syngenta<\/em>\uff08UPC_CoA_523\/2024\u30012025\u5e743\u67083\u65e5\uff09\u306e\u6d41\u308c\u306b\u6cbf\u3046\u3082\u306e\u3067\u3059\u3002\u624b\u7d9a\u898f\u5247206\u6761(2)(d)\u306e\u7dca\u6025\u6027\u306b\u3064\u3044\u3066\u306f\u3001\u7533\u7acb\u4eba\u304c\u884c\u52d5\u3092\u8d77\u3053\u3059\u3053\u3068\u3092\u53ef\u80fd\u306b\u3059\u308b\u4e8b\u5b9f\u3068\u8a3c\u62e0\u3092\u5165\u624b\u3057\u305f\u65e5\u304b\u3089\u8d77\u7b97\u3055\u308c\u307e\u3059\u3002\u3053\u306e\u8d77\u7b97\u70b9\u304b\u30896\u9031\u9593\u5f8c\u306b\u884c\u308f\u308c\u305f\u7533\u7acb\u3066\u306f\u3001\u6c42\u3081\u3089\u308c\u308b\u8fc5\u901f\u6027\u306e\u8981\u4ef6\u3092\u6e80\u305f\u3057\u3066\u3044\u307e\u3057\u305f\u3002<\/p>\n<h2>\u5730\u7406\u7684\u7bc4\u56f2\u3068\u6bd4\u4f8b\u6027<\/h2>\n<p>UPCA\u7b2c34\u6761\u306b\u3088\u308a\u3001UPC\u306e\u547d\u4ee4\u306f\u3001\u539f\u5247\u3068\u3057\u3066\u7279\u8a31\u304c\u52b9\u529b\u3092\u6709\u3059\u308b\u3059\u3079\u3066\u306e\u7de0\u7d04\u52a0\u76df\u56fd\u3001\u3059\u306a\u308f\u3061\u73fe\u6642\u70b9\u306718\u304b\u56fd\u306b\u53ca\u3073\u307e\u3059\u3002\u305f\u3060\u3057\u6bd4\u4f8b\u6027\u306b\u3088\u308b\u5236\u7d04\u3092\u53d7\u3051\u307e\u3059\u3002<em>Boehringer<\/em>\u4e8b\u4ef6\u3067\u767a\u305b\u3089\u308c\u305f\u66ab\u5b9a\u547d\u4ee4\u306f\u3001Zentiva\u304c\u30dd\u30eb\u30c8\u30ac\u30eb\u3067\u3057\u304b\u8ca9\u58f2\u627f\u8a8d\u3092\u6709\u3057\u3066\u3044\u306a\u304b\u3063\u305f\u306b\u3082\u304b\u304b\u308f\u3089\u305a\u3001UPC\u306e\u5168\u9818\u57df\u306b\u9069\u7528\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n<p>\u63a7\u8a34\u88c1\u5224\u6240\u306f\u3001\u81ea\u3089\u306f\u56fd\u5185\u6cd5\u3092\u9069\u7528\u3059\u308b\u306e\u3067\u306f\u306a\u304f\u3001\u56fd\u5185\u306e\u898f\u5236\u72b6\u6cc1\u3092\u4e8b\u5b9f\u4e0a\u306e\u4e8b\u60c5\u3068\u3057\u3066\u8003\u616e\u3059\u308b\u306b\u3068\u3069\u307e\u308b\u3053\u3068\u3092\u660e\u78ba\u306b\u793a\u3057\u307e\u3057\u305f\u3002\u3059\u3067\u306b<a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/FR\/TXT\/?uri=CELEX:32004L0048\" rel=\"nofollow\">\u6307\u4ee42004\/48\/CE<\/a>\u7b2c3\u6761\u7b2c2\u9805\u306b\u3088\u3063\u3066\u78ba\u7acb\u3055\u308c\u3066\u3044\u308b\u6bd4\u4f8b\u6027\u306f\u3001\u5404\u56fd\u306e\u4f1d\u7d71\u3068UPC\u3068\u3092\u67b6\u6a4b\u3059\u308b\u3082\u306e\u3067\u3059\u3002\u4e21\u5236\u5ea6\u306f\u3001\u5e02\u5834\u306e\u5177\u4f53\u7684\u306a\u5b9f\u614b\u306b\u57fa\u3065\u304f\u5229\u76ca\u306e\u7dcf\u5408\u7684\u306a\u8861\u91cf\u3078\u3068\u53ce\u6582\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<h2>\u5236\u5ea6\u306e\u53ce\u6582\u3068\u30ea\u30b9\u30af\u306e\u5730\u653f\u5b66<\/h2>\n<p>\u5f62\u5f0f\u4e0a\u306e\u76f8\u9055\u306e\u80cc\u5f8c\u306b\u3001\u5b9f\u8cea\u7684\u306a\u53ce\u6582\u304c\u6d6e\u304b\u3073\u4e0a\u304c\u3063\u3066\u3044\u307e\u3059\u3002\u30d5\u30e9\u30f3\u30b9\u306e\u88c1\u5224\u5b98\u3082UPC\u3082\u3001\u500b\u3005\u306e\u884c\u70ba\u3092\u6027\u8cea\u6c7a\u5b9a\u3059\u308b\u306e\u3067\u306f\u306a\u304f\u3001\u4e8b\u5b9f\u306e\u675f\u3092\u7dcf\u5408\u7684\u306b\u8a55\u4fa1\u3059\u308b\u65b9\u6cd5\u3092\u3068\u3063\u3066\u3044\u307e\u3059\u3002\u30d5\u30e9\u30f3\u30b9\u3067\u306f\u3001\u8ca9\u58f2\u627f\u8a8d\u306f\u4fb5\u5bb3\u884c\u70ba\u3067\u306f\u306a\u304f\u3001\u305d\u308c\u5358\u72ec\u3067\u5dee\u3057\u8feb\u3063\u305f\u8105\u5a01\u3068\u306a\u308b\u3082\u306e\u3067\u3082\u3042\u308a\u307e\u305b\u3093\uff08\u30d1\u30ea\u5927\u5be9\u88c1\u5224\u6240\u30012011\u5e744\u67085\u65e5\u3001<em>Novartis c. EG Labo<\/em>\u3001\u30d1\u30ea\u63a7\u8a34\u9662\u30012012\u5e743\u670821\u65e5\u3001<em>Novartis c. Mylan<\/em>\u3001\u30d1\u30ea\u63a7\u8a34\u9662\u30012013\u5e745\u670823\u65e5\u3001<em>Sanofi c. Arrow<\/em>\uff09\u3002\u3057\u304b\u3057\u3001CEPS\u3078\u306e\u65e9\u671f\u306e\u7533\u8acb\u3092\u4f34\u3046\u5834\u5408\u306b\u306f\u3001\u5dee\u3057\u8feb\u3063\u305f\u8105\u5a01\u306e\u8a8d\u5b9a\u306b\u5bc4\u4e0e\u3057\u3046\u308b\u306e\u3067\u3059\u3002UPC\u306e\u624b\u7d9a\u4e0a\u306e\u53b3\u683c\u3055\u306f\u3001\u7ffb\u3063\u3066\u5404\u56fd\u306e\u5b9f\u52d9\u611f\u899a\u3092\u990a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u305d\u306e\u5f8c\u306e\u5224\u4f8b\u306f\u3001\u3053\u306e\u69cb\u56f3\u3092\u3055\u3089\u306b\u7cbe\u7dfb\u5316\u3057\u307e\u3057\u305f\u3002<em>Merz c. Viatris<\/em>\uff08UPC_CoA_917\/2025\u30012026\u5e744\u670827\u65e5\uff09\u306b\u304a\u3044\u3066\u3001\u63a7\u8a34\u88c1\u5224\u6240\u306f\u3001\u7dca\u6025\u6027\u306e\u6642\u8a08\u306f\u6a29\u5229\u8005\u306e\u8a3c\u660e\u53ef\u80fd\u306a\u8a8d\u8b58\u304b\u3089\u9032\u307f\u59cb\u3081\u308b\u306e\u3067\u3042\u3063\u3066\u3001\u5404\u56fd\u306e\u898f\u5236\u4e0a\u306e\u30b7\u30b0\u30ca\u30eb\u304b\u3089\u5c0e\u304b\u308c\u308b\u5358\u306a\u308b\u63a8\u8a8d\u304b\u3089\u9032\u307f\u59cb\u3081\u308b\u306e\u3067\u306f\u306a\u3044\u3068\u660e\u3089\u304b\u306b\u3057\u307e\u3057\u305f\u3002\u5dee\u3057\u8feb\u3063\u305f\u4fb5\u5bb3\u306f\u5ba2\u89b3\u7684\u306b\u7acb\u8a3c\u3055\u308c\u307e\u3059\u3002\u3053\u308c\u306b\u5bfe\u3057\u3001\u7dca\u6025\u6027\u306f\u4e3b\u89b3\u7684\u306b\u8a3c\u660e\u3055\u308c\u307e\u3059\u3002\u4e21\u5224\u6c7a\u306f\u76f8\u307e\u3063\u3066\u3001\u533b\u85ac\u54c1\u5206\u91ce\u306b\u304a\u3051\u308b<a href=\"\/ja\/contentieux-des-brevets\/mesures-provisoires-refere\/\">\u66ab\u5b9a\u63aa\u7f6e<\/a>\u306e\u8a34\u8a1f\u306e\u65b0\u305f\u306a\u67a0\u7d44\u307f\u3092\u5f62\u3065\u304f\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5148\u767a\u4f01\u696d\u306b\u3068\u3063\u3066\u3001\u3053\u306e\u5ba2\u89b3\u7684\u57fa\u6e96\u306f\u72ec\u5360\u3078\u306e\u4fe1\u983c\u3092\u56de\u5fa9\u3055\u305b\u308b\u3082\u306e\u3067\u3059\u3002\u4e00\u3064\u306e<a href=\"\/ja\/lexique-propriete-intellectuelle\/action-en-interdiction-provisoire\/\">\u66ab\u5b9a\u7684\u5dee\u6b62\u3081\u306e\u8a34\u3048<\/a>\u306b\u3088\u3063\u3066\u7d71\u4e00\u3055\u308c\u305f\u6b27\u5dde\u5e02\u5834\u5168\u4f53\u3092\u4fdd\u8b77\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u3001\u5b9f\u969b\u306b\u767a\u58f2\u3055\u308c\u305f\u5834\u5408\u306b\u306f<a href=\"\/ja\/dommages-interets-devant-la-jub\/\">UPC\u306b\u304a\u3051\u308b\u640d\u5bb3\u8ce0\u511f<\/a>\u3082\u8996\u91ce\u306b\u5165\u308a\u307e\u3059\u3002\u5f8c\u767a\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u306b\u3068\u3063\u3066\u306f\u3001\u898f\u5236\u4e0a\u306e\u6e96\u5099\u3068\u7279\u8a31\u6e80\u4e86\u3068\u306e\u9593\u306e\u6642\u9593\u7684\u4f59\u5730\u304c\u7e2e\u307e\u308a\u3001<a href=\"\/ja\/forum-shopping-devant-la-jub\/\">UPC\u306b\u304a\u3051\u308b\u30d5\u30a9\u30fc\u30e9\u30e0\u30fb\u30b7\u30e7\u30c3\u30d4\u30f3\u30b0<\/a>\u306b\u95a2\u3059\u308b\u5f53\u4e8b\u52d9\u6240\u306e\u5206\u6790\u3067\u691c\u8a0e\u3057\u305f\u6cd5\u5ef7\u5730\u306e\u9078\u629e\u304c\u3001\u30ea\u30b9\u30af\u8a08\u7b97\u306e\u4e00\u8981\u7d20\u3068\u306a\u308a\u307e\u3059\u3002\u5404\u56fd\u3068\u30e8\u30fc\u30ed\u30c3\u30d1\u306e<a href=\"\/ja\/jub-contentieux-paralleles\/\">\u4e26\u884c\u8a34\u8a1f<\/a>\u306e\u9023\u643a\u306b\u3064\u3044\u3066\u3082\u540c\u69d8\u3067\u3059\u3002<\/p>\n<h2>\u8981\u70b9<\/h2>\n<ul>\n<li>UPC\u306f\u5dee\u3057\u8feb\u3063\u305f\u4fb5\u5bb3\u306b\u3064\u3044\u3066\u5ba2\u89b3\u7684\u57fa\u6e96\u3092\u9069\u7528\u3057\u3066\u3044\u307e\u3059\u3002\u3059\u306a\u308f\u3061\u3001\u6e96\u5099\u304c\u5b8c\u4e86\u3057\u3001\u767a\u58f2\u304c\u3082\u306f\u3084\u88ab\u544a\u306e\u6c7a\u5b9a\u306e\u307f\u306b\u4f9d\u5b58\u3059\u308b\u6bb5\u968e\u306b\u9054\u3057\u3066\u3044\u308b\u304b\u3092\u3001\u300c\u305d\u3046\u3067\u306a\u3044\u3088\u308a\u3082\u305d\u3046\u3067\u3042\u308b\u53ef\u80fd\u6027\u304c\u9ad8\u3044\u300d\u3068\u3044\u3046\u57fa\u6e96\u306b\u5f93\u3063\u3066\u5224\u65ad\u3057\u307e\u3059\uff08UPCA\u7b2c62\u6761(1)\u3001\u624b\u7d9a\u898f\u5247211\u6761(2)\uff09\u3002<\/li>\n<li><em>Boehringer c. Zentiva<\/em>\uff08UPC_CoA_446\/2025\u30012025\u5e748\u670813\u65e5\uff09\uff1a\u7570\u4f8b\u306b\u65e9\u304f\u53d6\u5f97\u3055\u308c\u305f\u4fa1\u683c\u8a55\u4fa1\u3001\u5165\u672d\u3078\u306e\u53c2\u52a0\u306e\u53ef\u80fd\u6027\u3001\u305d\u3057\u3066\u4fe1\u983c\u3067\u304d\u308b\u8aac\u660e\u306e\u6b20\u5982\u304c\u3042\u308c\u3070\u3001\u4fb5\u5bb3\u306e\u5dee\u3057\u8feb\u308a\u3092\u8a8d\u3081\u308b\u306b\u8db3\u308a\u307e\u3059\u3002<\/li>\n<li>\u767a\u58f2\u3057\u306a\u3044\u65e8\u306e\u4e00\u65b9\u7684\u306a\u5ba3\u8a00\u306f\u30ea\u30b9\u30af\u3092\u9664\u53bb\u3057\u307e\u305b\u3093\u3002\u8003\u616e\u3055\u308c\u308b\u306e\u306f\u3001\u78ba\u5b9a\u7684\u304b\u3064\u691c\u8a3c\u53ef\u80fd\u306a\u653e\u68c4\u306e\u307f\u3067\u3059\u3002<\/li>\n<li>\u533b\u85ac\u54c1\u30d1\u30c3\u30b1\u30fc\u30b8\u306b\u95a2\u3059\u308b2025\u5e7412\u6708\u306e\u66ab\u5b9a\u5408\u610f\u306f\u3001\u30dc\u30fc\u30e9\u30fc\u4f8b\u5916\u3092\u4fa1\u683c\u3001\u511f\u9084\u304a\u3088\u3073\u5165\u672d\u306b\u95a2\u3059\u308b\u624b\u7d9a\u306b\u307e\u3067\u62e1\u5f35\u3057\u307e\u3059\u304c\u3001\u767a\u58f2\u4f53\u5236\u305d\u306e\u3082\u306e\u306f\u5bfe\u8c61\u3068\u3057\u307e\u305b\u3093\u3002<\/li>\n<li>UPC\u306e\u547d\u4ee4\u306f\u3001\u539f\u5247\u3068\u3057\u3066\u7279\u8a31\u304c\u52b9\u529b\u3092\u6709\u3059\u308b\u3059\u3079\u3066\u306e\u7de0\u7d04\u56fd\u306b\u53ca\u3073\u307e\u3059\u3002\u88ab\u544a\u304c\u305d\u306e\u3046\u3061\u306e\u4e00\u304b\u56fd\u3067\u3057\u304b\u627f\u8a8d\u3092\u5f97\u3066\u3044\u306a\u3044\u5834\u5408\u3082\u540c\u69d8\u3067\u3059\u3002<\/li>\n<li><em>Merz c. Viatris<\/em>\uff082026\u5e744\u670827\u65e5\uff09\u4ee5\u964d\u3001\u7dca\u6025\u6027\u306f\u898f\u5236\u4e0a\u306e\u4e8b\u60c5\u304b\u3089\u306e\u63a8\u5b9a\u3067\u306f\u306a\u304f\u3001\u7acb\u8a3c\u53ef\u80fd\u306a\u8a8d\u8b58\u306b\u3088\u3063\u3066\u8a3c\u660e\u3055\u308c\u307e\u3059\u3002<\/li>\n<\/ul>\n<h2>\u3088\u304f\u3042\u308b\u3054\u8cea\u554f<\/h2>\n<h3>UPC\u306b\u304a\u3051\u308b\u5dee\u3057\u8feb\u3063\u305f\u4fb5\u5bb3\u3068\u306f\u4f55\u3067\u3059\u304b\u3002<\/h3>\n<p>\u4fb5\u5bb3\u3068\u306a\u308b\u5b9f\u65bd\u306e\u305f\u3081\u306e\u6e96\u5099\u304c\u3059\u3079\u3066\u5b8c\u4e86\u3057\u3001\u767a\u58f2\u304c\u3082\u306f\u3084\u88ab\u544a\u306e\u6c7a\u5b9a\u306e\u307f\u306b\u4f9d\u5b58\u3057\u3066\u3044\u308b\u72b6\u6cc1\u3092\u3044\u3044\u307e\u3059\u3002\u3053\u306e\u5834\u5408\u3001UPCA\u7b2c62\u6761(1)\u306b\u3088\u308a\u3001\u8ca9\u58f2\u884c\u70ba\u304c\u884c\u308f\u308c\u308b\u524d\u306b\u66ab\u5b9a\u63aa\u7f6e\u3092\u5f97\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>\n<h3>\u8ca9\u58f2\u627f\u8a8d\uff08AMM\uff09\u3060\u3051\u3067\u4fb5\u5bb3\u306e\u5dee\u3057\u8feb\u308a\u306f\u8a8d\u3081\u3089\u308c\u307e\u3059\u304b\u3002<\/h3>\n<p>\u3044\u3044\u3048\u3002\u30d5\u30e9\u30f3\u30b9\u3067\u3082UPC\u3067\u3082\u8a8d\u3081\u3089\u308c\u307e\u305b\u3093\u3002\u8ca9\u58f2\u627f\u8a8d\u306f\u5fb4\u8868\u306e\u675f\u3092\u69cb\u6210\u3059\u308b\u4e00\u8981\u7d20\u306b\u3059\u304e\u305a\u3001\u65e9\u671f\u306e\u4fa1\u683c\u7533\u8acb\u3084\u3001\u4fe1\u983c\u3067\u304d\u308b\u6b63\u5f53\u5316\u7406\u7531\u306e\u306a\u3044\u5165\u672d\u3078\u306e\u53c2\u52a0\u306a\u3069\u3001\u4ed6\u306e\u884c\u70ba\u3068\u7d44\u307f\u5408\u308f\u3055\u308c\u3066\u521d\u3081\u3066\u8a3c\u660e\u529b\u3092\u6301\u3061\u307e\u3059\u3002<\/p>\n<h3>\u30a2\u30c3\u30c8\u30ea\u30b9\u30af\u30fb\u30ed\u30fc\u30f3\u30c1\u3068\u306f\u4f55\u3067\u3059\u304b\u3002\u307e\u305f\u3001UPC\u306f\u3053\u308c\u3092\u3069\u306e\u3088\u3046\u306b\u6271\u3063\u3066\u3044\u307e\u3059\u304b\u3002<\/h3>\n<p>\u30a2\u30c3\u30c8\u30ea\u30b9\u30af\u30fb\u30ed\u30fc\u30f3\u30c1\u3068\u306f\u3001\u7279\u8a31\u307e\u305f\u306f\u88dc\u5145\u7684\u4fdd\u8b77\u8a3c\u660e\u66f8\uff08SPC\uff09\u306e\u6e80\u4e86\u524d\u306b\u3001\u305d\u308c\u3089\u306e\u7121\u52b9\u306b\u8ced\u3051\u3066\u5f8c\u767a\u533b\u85ac\u54c1\u3092\u8ca9\u58f2\u3059\u308b\u3053\u3068\u3067\u3059\u3002<em>Boehringer<\/em>\u5224\u4f8b\u306f\u3001\u6a29\u5229\u8005\u304c\u6e96\u5099\u6bb5\u968e\u304b\u3089UPC\u306e\u5168\u9818\u57df\u306b\u304a\u3044\u3066\u63aa\u7f6e\u3092\u8b1b\u3058\u308b\u3053\u3068\u3092\u53ef\u80fd\u306b\u3059\u308b\u3053\u3068\u3067\u3001\u3053\u306e\u6226\u7565\u306e\u4f59\u5730\u3092\u72ed\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n<h3>\u5f8c\u767a\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u306f\u3069\u306e\u3088\u3046\u306b\u3057\u3066\u30ea\u30b9\u30af\u3092\u8efd\u6e1b\u3067\u304d\u307e\u3059\u304b\u3002<\/h3>\n<p>\u898f\u5236\u4e0a\u306e\u624b\u7d9a\u306e\u6642\u671f\u3092\u614e\u91cd\u306b\u8abf\u6574\u3059\u308b\u3053\u3068\u3001\u5404\u6bb5\u968e\u306e\u6b63\u5f53\u5316\u7406\u7531\u3092\u8a18\u9332\u3057\u3066\u304a\u304f\u3053\u3068\u3001\u5fc5\u8981\u306b\u5fdc\u3058\u3066\u767a\u58f2\u306e\u78ba\u5b9a\u7684\u306a\u653e\u68c4\u3092\u7d04\u3059\u308b\u3053\u3068\u3001\u305d\u3057\u3066UPC\u306b<a href=\"\/ja\/lexique-propriete-intellectuelle\/memoire-preventif\/\">\u4fdd\u8b77\u66f8\u9762\uff08m\u00e9moire pr\u00e9ventif\uff09<\/a>\u3092\u63d0\u51fa\u3057\u3001\u4e00\u65b9\u5f53\u4e8b\u8005\u306e\u307f\u306e\u624b\u7d9a\uff08ex parte\uff09\u306b\u3088\u308b\u63aa\u7f6e\u306e\u524d\u306b\u610f\u898b\u3092\u8ff0\u3079\u308b\u6a5f\u4f1a\u3092\u78ba\u4fdd\u3059\u308b\u3053\u3068\u3067\u3059\u3002<\/p>\n<p>Dhenne Avocats\u306f\u3001\u5148\u767a\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u3068\u5f8c\u767a\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u306b\u5bfe\u3057\u3001\u767a\u58f2\u6226\u7565\u3001UPC\u306b\u304a\u3051\u308b\u66ab\u5b9a\u63aa\u7f6e\u3001\u533b\u85ac\u54c1\u7279\u8a31\u8a34\u8a1f\u306b\u3064\u3044\u3066\u3001<a href=\"\/ja\/domaines-d-expertise\/avocat-reglementation-pharmaceutique\/\">\u533b\u85ac\u54c1\u898f\u5236<\/a>\u306e\u89b3\u70b9\u3082\u8e0f\u307e\u3048\u3066\u52a9\u8a00\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002<a href=\"\/ja\/contact\/\">\u3054\u76f8\u8ac7\u306f\u3053\u3061\u3089<\/a>\u3002<\/p>\n<p><em>\u672c\u7a3f\u306f\u3001Matthieu Dhenne\u304c2025\u5e7410\u670830\u65e5\u306bKluwer Patent Blog\u306b\u6700\u521d\u306b\u767a\u8868\u3057\u305f\u5206\u6790\u3092\u3001\u72ec\u81ea\u306b\u7ffb\u6848\u3057\u3001\u5927\u5e45\u306b\u66f4\u65b0\u3057\u305f\u3082\u306e\u3067\u3059\uff1a<a href=\"https:\/\/legalblogs.wolterskluwer.com\/patent-blog\/imminent-infringement-the-upcs-new-geography-of-pharmaceutical-risk\/\" rel=\"nofollow\">Imminent Infringement: The UPC\u2019s New Geography of Pharmaceutical Risk<\/a>\u3002<\/em><br \/>\n<!-- dhenne-watch-pharma --><\/p>\n<p>UPC\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u5206\u91ce\u306e\u6c7a\u5b9a\u306f\u3001<a href=\"\/ja\/pharma-litigation-watch\/\">Pharma Litigation Watch<\/a>\u306b\u53ce\u9332\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\n<!-- \/dhenne-watch-pharma --><\/p>\n<p><br \/>\n<br \/>\n<\/p>\n<p>\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u5206\u91ce\u306eUPC\u306e\u5224\u6c7a\u306f\u3001<a href=\"\/ja\/pharma-litigation-watch\/\">Pharma Litigation Watch<\/a>\u306b\u53ce\u9332\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p><!-- \/dhenne-watch-pharma --><\/p>","protected":false},"excerpt":{"rendered":"<p>Avec l&rsquo;arr\u00eat Boehringer c. Zentiva (13 ao\u00fbt 2025), la JUB fait de la contrefa\u00e7on imminente un test objectif de probabilit\u00e9 : la pr\u00e9paration du lancement d&rsquo;un g\u00e9n\u00e9rique peut suffire \u00e0 d\u00e9clencher des mesures provisoires sur tout le territoire des \u00c9tats contractants.<\/p>","protected":false},"author":4,"featured_media":16445,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[41,7,28],"tags":[],"class_list":["post-11068","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-action-en-interdiction-provisoire","category-jub","category-pharmaceutique"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Contrefa\u00e7on imminente devant la JUB : lancement \u00e0 risque<\/title>\n<meta name=\"description\" content=\"Contrefa\u00e7on imminente devant la JUB : le test objectif issu de Boehringer c. Zentiva, les limites de l&#039;exception Bolar et la port\u00e9e territoriale.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dhenne-avocats.fr\/ja\/contrefacon-imminente-jub-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Contrefa\u00e7on imminente devant la JUB : lancement \u00e0 risque\" \/>\n<meta property=\"og:description\" content=\"Contrefa\u00e7on imminente devant la JUB : le test objectif issu de Boehringer c. Zentiva, les limites de l&#039;exception Bolar et la port\u00e9e territoriale.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dhenne-avocats.fr\/ja\/contrefacon-imminente-jub-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Dhenne Avocats\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-03T15:10:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-23T13:02:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2026\/10\/hokusai-la-grande-vague-de-kanagawa.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1314\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Matthieu Dhenne\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@matthieu_dhenne\" \/>\n<meta name=\"twitter:site\" content=\"@DhenneAvocats\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Matthieu Dhenne\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"9\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/contrefacon-imminente-jub-pharma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/contrefacon-imminente-jub-pharma\\\/\"},\"author\":{\"name\":\"Matthieu Dhenne\",\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/#\\\/schema\\\/person\\\/cebb642899b1d41301d41a0187fa329c\"},\"headline\":\"Contrefa\u00e7on imminente devant la JUB : la nouvelle g\u00e9ographie du risque pharmaceutique\",\"datePublished\":\"2026-09-03T15:10:00+00:00\",\"dateModified\":\"2026-10-23T13:02:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/contrefacon-imminente-jub-pharma\\\/\"},\"wordCount\":3841,\"publisher\":{\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/contrefacon-imminente-jub-pharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/hokusai-la-grande-vague-de-kanagawa.jpg\",\"articleSection\":[\"Action en interdiction provisoire\",\"JUB\",\"Pharmaceutique\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/contrefacon-imminente-jub-pharma\\\/\",\"url\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/contrefacon-imminente-jub-pharma\\\/\",\"name\":\"Contrefa\u00e7on imminente devant la JUB : lancement \u00e0 risque\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/contrefacon-imminente-jub-pharma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/contrefacon-imminente-jub-pharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/hokusai-la-grande-vague-de-kanagawa.jpg\",\"datePublished\":\"2026-09-03T15:10:00+00:00\",\"dateModified\":\"2026-10-23T13:02:14+00:00\",\"description\":\"Contrefa\u00e7on imminente devant la JUB : le test objectif issu de Boehringer c. Zentiva, les limites de l'exception Bolar et la port\u00e9e territoriale.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/contrefacon-imminente-jub-pharma\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.dhenne-avocats.fr\\\/contrefacon-imminente-jub-pharma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/contrefacon-imminente-jub-pharma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/hokusai-la-grande-vague-de-kanagawa.jpg\",\"contentUrl\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/hokusai-la-grande-vague-de-kanagawa.jpg\",\"width\":1920,\"height\":1314,\"caption\":\"Katsushika Hokusai, La Grande Vague de Kanagawa, vers 1830-1832. Wikimedia Commons, domaine public.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/contrefacon-imminente-jub-pharma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Contrefa\u00e7on imminente devant la JUB : la nouvelle g\u00e9ographie du risque pharmaceutique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/#website\",\"url\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/\",\"name\":\"Dhenne Avocats\",\"description\":\"Cabinet d&#039;avocats en droit des brevets\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/#organization\",\"name\":\"Dhenne Avocats\",\"alternateName\":\"dhenne avocats\",\"url\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/cropped-DhenneAvocats_Favicon_RVB_FullColor-1.png\",\"contentUrl\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/cropped-DhenneAvocats_Favicon_RVB_FullColor-1.png\",\"width\":512,\"height\":512,\"caption\":\"Dhenne Avocats\"},\"image\":{\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/DhenneAvocats\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dhenne-avocat\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.dhenne-avocats.fr\\\/#\\\/schema\\\/person\\\/cebb642899b1d41301d41a0187fa329c\",\"name\":\"Matthieu Dhenne\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/988db4ff705a27432f0176d0317044da13eaf4eee82d9246f7cf81f2504e05c4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/988db4ff705a27432f0176d0317044da13eaf4eee82d9246f7cf81f2504e05c4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/988db4ff705a27432f0176d0317044da13eaf4eee82d9246f7cf81f2504e05c4?s=96&d=mm&r=g\",\"caption\":\"Matthieu Dhenne\"},\"description\":\"Avocat au barreau de Paris depuis 2014, docteur en droit, fondateur de Dhenne Avocats, cabinet d\u00e9di\u00e9 au contentieux des brevets d\u2019invention. Repr\u00e9sentant devant la Juridiction unifi\u00e9e du brevet. Enseigne le droit de la propri\u00e9t\u00e9 industrielle \u00e0 l\u2019Universit\u00e9 Panth\u00e9on-Assas et assure la correspondance fran\u00e7aise du Kluwer Patent Blog.\",\"sameAs\":[\"https:\\\/\\\/www.dhenne-avocats.fr\\\/equipe-nos-avocats-brevets\\\/matthieu-dhenne\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/matthieudhenne\\\/\",\"https:\\\/\\\/x.com\\\/matthieu_dhenne\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UPC\u306b\u304a\u3051\u308b\u5dee\u3057\u8feb\u3063\u305f\u4fb5\u5bb3\uff1a\u30a2\u30c3\u30c8\u30ea\u30b9\u30af\u30fb\u30ed\u30fc\u30f3\u30c1","description":"UPC\u306b\u304a\u3051\u308b\u5dee\u3057\u8feb\u3063\u305f\u4fb5\u5bb3\u306b\u3064\u3044\u3066\u3001Boehringer c. Zentiva\u5224\u6c7a\u304c\u793a\u3057\u305f\u5ba2\u89b3\u7684\u57fa\u6e96\u3001\u30dc\u30fc\u30e9\u30fc\u4f8b\u5916\u306e\u9650\u754c\u3001UPC\u306e\u547d\u4ee4\u304c\u53ca\u3076\u5730\u7406\u7684\u7bc4\u56f2\u3092\u5f53\u4e8b\u52d9\u6240\u304c\u89e3\u8aac\u3057\u307e\u3059\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dhenne-avocats.fr\/ja\/contrefacon-imminente-jub-pharma\/","og_locale":"ja_JP","og_type":"article","og_title":"Contrefa\u00e7on imminente devant la JUB : lancement \u00e0 risque","og_description":"Contrefa\u00e7on imminente devant la JUB : le test objectif issu de Boehringer c. Zentiva, les limites de l'exception Bolar et la port\u00e9e territoriale.","og_url":"https:\/\/www.dhenne-avocats.fr\/ja\/contrefacon-imminente-jub-pharma\/","og_site_name":"Dhenne Avocats","article_published_time":"2026-09-03T15:10:00+00:00","article_modified_time":"2026-10-23T13:02:14+00:00","og_image":[{"width":1920,"height":1314,"url":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2026\/10\/hokusai-la-grande-vague-de-kanagawa.jpg","type":"image\/jpeg"}],"author":"Matthieu Dhenne","twitter_card":"summary_large_image","twitter_creator":"@matthieu_dhenne","twitter_site":"@DhenneAvocats","twitter_misc":{"\u57f7\u7b46\u8005":"Matthieu Dhenne","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"9\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.dhenne-avocats.fr\/contrefacon-imminente-jub-pharma\/#article","isPartOf":{"@id":"https:\/\/www.dhenne-avocats.fr\/contrefacon-imminente-jub-pharma\/"},"author":{"name":"Matthieu Dhenne","@id":"https:\/\/www.dhenne-avocats.fr\/#\/schema\/person\/cebb642899b1d41301d41a0187fa329c"},"headline":"Contrefa\u00e7on imminente devant la JUB : la nouvelle g\u00e9ographie du risque pharmaceutique","datePublished":"2026-09-03T15:10:00+00:00","dateModified":"2026-10-23T13:02:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.dhenne-avocats.fr\/contrefacon-imminente-jub-pharma\/"},"wordCount":3841,"publisher":{"@id":"https:\/\/www.dhenne-avocats.fr\/#organization"},"image":{"@id":"https:\/\/www.dhenne-avocats.fr\/contrefacon-imminente-jub-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2026\/10\/hokusai-la-grande-vague-de-kanagawa.jpg","articleSection":["Action en interdiction provisoire","JUB","Pharmaceutique"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/www.dhenne-avocats.fr\/contrefacon-imminente-jub-pharma\/","url":"https:\/\/www.dhenne-avocats.fr\/contrefacon-imminente-jub-pharma\/","name":"UPC\u306b\u304a\u3051\u308b\u5dee\u3057\u8feb\u3063\u305f\u4fb5\u5bb3\uff1a\u30a2\u30c3\u30c8\u30ea\u30b9\u30af\u30fb\u30ed\u30fc\u30f3\u30c1","isPartOf":{"@id":"https:\/\/www.dhenne-avocats.fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.dhenne-avocats.fr\/contrefacon-imminente-jub-pharma\/#primaryimage"},"image":{"@id":"https:\/\/www.dhenne-avocats.fr\/contrefacon-imminente-jub-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2026\/10\/hokusai-la-grande-vague-de-kanagawa.jpg","datePublished":"2026-09-03T15:10:00+00:00","dateModified":"2026-10-23T13:02:14+00:00","description":"UPC\u306b\u304a\u3051\u308b\u5dee\u3057\u8feb\u3063\u305f\u4fb5\u5bb3\u306b\u3064\u3044\u3066\u3001Boehringer c. Zentiva\u5224\u6c7a\u304c\u793a\u3057\u305f\u5ba2\u89b3\u7684\u57fa\u6e96\u3001\u30dc\u30fc\u30e9\u30fc\u4f8b\u5916\u306e\u9650\u754c\u3001UPC\u306e\u547d\u4ee4\u304c\u53ca\u3076\u5730\u7406\u7684\u7bc4\u56f2\u3092\u5f53\u4e8b\u52d9\u6240\u304c\u89e3\u8aac\u3057\u307e\u3059\u3002","breadcrumb":{"@id":"https:\/\/www.dhenne-avocats.fr\/contrefacon-imminente-jub-pharma\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dhenne-avocats.fr\/contrefacon-imminente-jub-pharma\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.dhenne-avocats.fr\/contrefacon-imminente-jub-pharma\/#primaryimage","url":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2026\/10\/hokusai-la-grande-vague-de-kanagawa.jpg","contentUrl":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2026\/10\/hokusai-la-grande-vague-de-kanagawa.jpg","width":1920,"height":1314,"caption":"Katsushika Hokusai, La Grande Vague de Kanagawa, vers 1830-1832. Wikimedia Commons, domaine public."},{"@type":"BreadcrumbList","@id":"https:\/\/www.dhenne-avocats.fr\/contrefacon-imminente-jub-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.dhenne-avocats.fr\/"},{"@type":"ListItem","position":2,"name":"Contrefa\u00e7on imminente devant la JUB : la nouvelle g\u00e9ographie du risque pharmaceutique"}]},{"@type":"WebSite","@id":"https:\/\/www.dhenne-avocats.fr\/#website","url":"https:\/\/www.dhenne-avocats.fr\/","name":"Dhenne Avocats","description":"\u30d1\u30ea\u306e\u7279\u8a31\u8a34\u8a1f\u30d6\u30c6\u30a3\u30c3\u30af","publisher":{"@id":"https:\/\/www.dhenne-avocats.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dhenne-avocats.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/www.dhenne-avocats.fr\/#organization","name":"Dhenne Avocats","alternateName":"dhenne avocats","url":"https:\/\/www.dhenne-avocats.fr\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.dhenne-avocats.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/cropped-DhenneAvocats_Favicon_RVB_FullColor-1.png","contentUrl":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/cropped-DhenneAvocats_Favicon_RVB_FullColor-1.png","width":512,"height":512,"caption":"Dhenne Avocats"},"image":{"@id":"https:\/\/www.dhenne-avocats.fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/DhenneAvocats","https:\/\/www.linkedin.com\/company\/dhenne-avocat\/"]},{"@type":"Person","@id":"https:\/\/www.dhenne-avocats.fr\/#\/schema\/person\/cebb642899b1d41301d41a0187fa329c","name":"\u30de\u30c1\u30e5\u30fc\u30fb\u30c7\u30f3\u30cc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/secure.gravatar.com\/avatar\/988db4ff705a27432f0176d0317044da13eaf4eee82d9246f7cf81f2504e05c4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/988db4ff705a27432f0176d0317044da13eaf4eee82d9246f7cf81f2504e05c4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/988db4ff705a27432f0176d0317044da13eaf4eee82d9246f7cf81f2504e05c4?s=96&d=mm&r=g","caption":"Matthieu Dhenne"},"description":"Avocat au barreau de Paris depuis 2014, docteur en droit, fondateur de Dhenne Avocats, cabinet d\u00e9di\u00e9 au contentieux des brevets d\u2019invention. Repr\u00e9sentant devant la Juridiction unifi\u00e9e du brevet. Enseigne le droit de la propri\u00e9t\u00e9 industrielle \u00e0 l\u2019Universit\u00e9 Panth\u00e9on-Assas et assure la correspondance fran\u00e7aise du Kluwer Patent Blog.","sameAs":["https:\/\/www.dhenne-avocats.fr\/equipe-nos-avocats-brevets\/matthieu-dhenne\/","https:\/\/www.linkedin.com\/in\/matthieudhenne\/","https:\/\/x.com\/matthieu_dhenne"]}]}},"_links":{"self":[{"href":"https:\/\/www.dhenne-avocats.fr\/ja\/wp-json\/wp\/v2\/posts\/11068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dhenne-avocats.fr\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dhenne-avocats.fr\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dhenne-avocats.fr\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dhenne-avocats.fr\/ja\/wp-json\/wp\/v2\/comments?post=11068"}],"version-history":[{"count":8,"href":"https:\/\/www.dhenne-avocats.fr\/ja\/wp-json\/wp\/v2\/posts\/11068\/revisions"}],"predecessor-version":[{"id":16981,"href":"https:\/\/www.dhenne-avocats.fr\/ja\/wp-json\/wp\/v2\/posts\/11068\/revisions\/16981"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dhenne-avocats.fr\/ja\/wp-json\/wp\/v2\/media\/16445"}],"wp:attachment":[{"href":"https:\/\/www.dhenne-avocats.fr\/ja\/wp-json\/wp\/v2\/media?parent=11068"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dhenne-avocats.fr\/ja\/wp-json\/wp\/v2\/categories?post=11068"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dhenne-avocats.fr\/ja\/wp-json\/wp\/v2\/tags?post=11068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}